Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery
Clinical trial NCT03647774 · COMPLETED
Trial details
- NCT number
- NCT03647774
- Sponsor
- Lars Tanum
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2022-10-13
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.